Advanced Cardiac MRI

Integrating AI and Machine Learning for Post Imaging Reconstruction

Review (2025)
Author(s)

Archana Vadiraj Malagi (Cedars-Sinai Medical Center, Los Angeles)

Xinqi Li (Cedars-Sinai Medical Center, Los Angeles)

Qian Tao (TU Delft - ImPhys/Tao group)

Hsin Jung Yang (Cedars-Sinai Medical Center, Los Angeles)

Research Group
ImPhys/Tao group
DOI related publication
https://doi.org/10.1007/s11936-025-01116-z
More Info
expand_more
Publication Year
2025
Language
English
Research Group
ImPhys/Tao group
Issue number
1
Volume number
27
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

Purpose of Review: This review explores the advancements in deep learning (DL)-based cardiac magnetic resonance (CMR) reconstruction, focusing on its role in accelerating imaging, denoising, super-resolution, motion artifact correction, and quantitative mapping. It highlights the transition from parallel imaging and compressed sensing to artificial intelligence (AI)-driven approaches that enhance image quality and diagnostic accuracy. Recent Findings: Supervised and self-supervised DL models can significantly reduce scan times, enabling high-fidelity reconstructions from undersampled data. Generative adversarial network (GAN)-based super-resolution techniques enhance spatial resolution, while denoising networks improve signal-to-noise ratio. Motion correction strategies, including spatiotemporal learning, have enhanced free-breathing acquisitions. Physics-guided models incorporate MRI signal constraints for improved T1/T2 mapping and myocardial tissue characterization. Summary: DL-driven CMR reconstruction optimizes imaging speed, quality, and artifact suppression. Despite challenges in dataset standardization and clinical validation, AI is advancing real-time, high-fidelity CMR, facilitating broader clinical adoption.